Search by Drug Name or NDC

NDC 69489-0212-30 ZILXI 15 mg/g Details

ZILXI 15 mg/g

ZILXI is a TOPICAL AEROSOL, FOAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Journey Medical Corporation. The primary component is MINOCYCLINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Minocycline topical (Amzeeq) is used to treat certain types of acne in adults and children 9 years of age and older. Minocyclinetopical (Zilxi) is used to treat inflammatory lesions of rosacea in adults. Minocycline is in a class of medications called tetracycline antibiotics. It works to treat acne by killing the bacteria that infects pores and decreasing a certain natural oily substance that causes acne.

Related Packages: 69489-0212-30
Last Updated: 05/05/2024
MedLinePlus Full Drug Details: Minocycline Topical

Product Information

NDC	69489-0212
Product ID	69489-212_4ab22cac-50b3-4814-8eac-a6c41700462b
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	ZILXI
Proprietary Name Suffix	n/a
Non-Proprietary Name	Minocycline
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	AEROSOL, FOAM
Route	TOPICAL
Active Ingredient Strength	15
Active Ingredient Units	mg/g
Substance Name	MINOCYCLINE HYDROCHLORIDE
Labeler Name	Journey Medical Corporation
Pharmaceutical Class	Decreased Prothrombin Activity [PE], Tetracycline-class Drug [EPC], Tetracyclines [CS]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA213690
Listing Certified Through	2024-12-31

Package

NDC 69489-0212-30 (69489021230)

Pricing Information	N/A
NDC Package Code	69489-212-30
Billing NDC	69489021230
Package	1 CAN in 1 CARTON (69489-212-30) / 30 g in 1 CAN
Marketing Start Date	2023-06-01
NDC Exclude Flag	N